Development of GPC3-CAR-NK cells and optimization as a therapy for HCC

Hepatocellular carcinoma (HCC) is a highly malignant tumor characterized by insidious onset and rapid progression, with limited treatment choices. One treatment modality, chimeric antigen receptor (CAR)-modified natural killer (NK) cell immunotherapy, has shown promise for various cancers. In this s...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of leukocyte biology 2024-06
Hauptverfasser:	Cao, Bihui, Ni, Qianqian, Chen, Zhuxin, Yang, Shuo, Zhang, Xinkui, Su, Haotao, Zhang, Zhenfeng, Zhao, Qi, Zhu, Xiaolan, Liu, Manting
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!